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Abstract
Background: Lomentospora prolificans (formally Scedosporium prolificans) is an environmental mould with a global
distribution. Endocarditis caused by L. prolificans is a rare but serious emerging disease in immunocompromised
patients. Prior to this case there have only been eight cases reported in the literature. Diagnosis can be challenging
and there are no evidence-based guidelines for treatment.
Case presentation: We report a 75-year-old woman with ovarian carcinoma who presented with fever after
chemotherapy. Repeated sterile site cultures remained negative until day 22 of admission, when Lomentospora
prolificans was isolated from blood cultures. Following extensive investigations, including Fluoro-D-glucose positron
emission tomography (FDG-PET) and transoephageal echocardiography (TOE), the patient was diagnosed with
endocarditis complicated by cerebral emboli. The patient was considered unsuitable for surgical intervention and
passed away five days after the fungus was isolated.
Conclusion: Endocarditis caused by Lomentospora prolificans is a rare but emerging condition, with limited
treatment options and a high mortality. Awareness of the increasing incidence of Lomentospora prolificans infection,
diagnosed often at an advanced stage, with potential for endocarditis may prompt earlier echocardiography or
FDG-PET imaging. Further studies are needed to determine the optimal combination and duration of anti-fungal
agents, used in conjunction with aggressive surgical excision where feasible.
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Background
Lomentospora prolificans, formally referred to as Scedos-
porium prolificans, is a dermatiaceous mould with a glo-
bal distribution, and is an emerging pathogen linked to
severe infections, particularly in the immunocomprom-
ised [1, 2]. Recently in Australia, L. prolificans was re-
ported amongst the most frequently isolated invasive
mould infections, possibly related to the abundance in
soil, particularly in urban environments [3]. Traditional
risk factors for infection include lung disease, malig-
nancy, transplantation, trauma and HIV positivity [1–3].
More recently, patients with chronic lung disease and
rheumatological conditions may be considered at-risk
[3]. Epidemiological data is emerging to include expos-
ure to antifungal prophylaxis, admission to the intensive
care department and proximity to hospital construction
work as likely predisposing factors for infection [3].
Recent reclassification of Scedosporium prolificans to
Lomentospora prolificans arose from fundamental changes
in the International Code of Nomenclature based on
phylogenetic profiling and combined international my-
cology working party recommendations in 2014 [4]. L.
prolificans is distinguished from the other Scedospor-
ium species both by morphological and clinical fea-
tures. Microscopically, the annelids have a typically
swollen or inflated rather than tubular base with apical
flask-shaped conidia and macroscopically a different col-
ony texture and colouration. Clinically, Lomentospora
cause serious disseminated infections, particularly in im-
munosuppressed hosts. Its typical high-level in-vivo resist-
ance to voriconazole sets it apart [4].
Clinical manifestations are varied. Focal bone and joint
infections in post-traumatic or post-operative patient
groups have been well described in the immunocompetent
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host. Disseminated disease is more common in the im-
munosuppressed cohort and can present in myriad forms.
Respiratory, ophthalmic, cerebral, skin and soft tissue
lesions along with endocarditis have been described [1].
Generally, Scedosporium spp are readily isolated from
sterile site culture and identified by their characteris-
tic macroscopic and microscopic morphology. Despite
this, blood culture isolation is typically late in the ill-
ness and thus has limited diangnostic utility, though
blood culture positivity may indicate widely dissemi-
nated disease [2]. Infective endocarditis caused by L.
prolificans has rarely been identified [1, 3, 5].
Diagnosis of endocarditis depends upon clinical criteria,
microbiological sampling and imaging, typically with
transoesophageal echocardiography (TOE). The role of
Fluoro-D-glucose positron emission tomography (FDG-
PET) in the diagnostic armamentarium for fever of
unknown origin, including endocarditis is emerging [6].
Recently, the European Society of Cardiology Guidelines
have incorporated FDG-PET scanning in the diagnos-
tic algorithm for prosthetic valve endocarditis when
the diagnosis is unable to be reached definitively with
traditional criteria [7]. Furthermore, high sensitivity
and good specificity, allow non-invasive FDG-PET
scanning to guide more targeted invasive diagnostics
such as transoesophageal echocardiography, as in this
case.
Case presentation
We report a 75-year-old female with stage IV poorly dif-
ferentiated ovarian carcinoma diagnosed in 2000, on pal-
liative carboplatin-based chemotherapy since 2011. Past
treatment included bilateral salpingo-oopherectomy and
hysterectomy, ileostomy due to small bowel obstruction
with subsequent fistulae formation and bilateral nephrost-
omy drainage after radiation-induced ureteric obstruction.
She had experienced recurrent urinary tract infections
and nephrostomies were previously colonised with methi-
cillin resistant Staphylococcus aureus (MRSA), Staphylo-
coccus epidermidis & Candida albicans. She had never
received anti-fungal prophylaxis. Co-morbidities included
hypertension, multiple pulmonary emboli on enoxa-
parin and paroxysmal atrial fibrillation. There were
building works underway in the hospital during her
hospital admission, although she was not in the
immediate vicinity.
The patient was admitted to hospital due to a brief
syncopal episode with associated lethargy, nausea,
light-headedness and increased watery ileostomal out-
put following chemotherapy one week earlier. Clinical
examination including central nervous system was
unremarkable, and she was haemodynamically stable
and afebrile. Laboratory investigations revealed sodium
127 mg/mL (135–145 mg/mL), creatinine 145 mg/mL
(45–90 mg/mL), haemoglobin 87 g/L (115–165 g/L),
white cell count 4.52 cells/μl (3.9–11.1 cells/μl) and
lymphocyte count 0.7 cells/μl (1.0–4.0 cells/μl). On
day 2 of admission, she developed fevers of 38.5 °C and
was empirically commenced on piperacillin-tazobactam
and vancomycin. Staphylococcus epidermidis isolated from
the nephrostomy fluid was considered colonisation and
the nephrostomies were changed. Initial septic screen was
non-contributory, including negative faecal microscopy.
Persisting fever during her third week of admission,
with negative sterile site cultures 14 days into her admis-
sion, prompted assessment for metastatic disease pro-
gression with FDG-PET scan. There was no evidence of
metastatic malignant disease detected, but an area of ab-
normal avidity was identified on the aortic valve (Fig. 1a).
Subsequent transthoracic echocardiogram (TTE) revealed
a small mobile echo-density superior to the aortic valve.
Transoesophageal echocardiogram (TOE) (Fig. 1b) re-
vealed a pedunculated mass within the ascending aorta
arising from the commissure of the right & non-coronary
b ca
Fig. 1 Diagnostic imaging of Lomentospora prolificans endocarditis. a FDG-PET axial image showing abnormal linear uptake in the aortic root and the
ascending aorta and b Transoesophageal echocardiogram (still shot) axial view demonstrating a large pedunculated mass within the ascending aorta
arising from the commissure of the right and non-coronary cusp of the aortic valve with a calcified base; and cerebral emboli c MRI brain axial view,
with some motion artefact, showing post-gadolinium enhancement of the right parasagittal frontal lobe consistent with an embolic lesion
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cusp of the aortic valve with a calcified base (20 × 14 ×
11mm). An additional movie file shows this in more detail
[see Additional file 1].
The patient became delirious on day 17 with a fluctu-
ating level of consciousness. Brain MRI identified a
contrast-enhancing right parasagittal frontal lobe lesion
consistent with an embolic lesion (Fig. 1c).
On day 22 of admission, fungi were isolated from
repeat blood cultures after 3 days of incubation using
the automated BacT/ALERT 3D system (bioMerieux,
USA) subsequently morphologically identified as Lomen-
tospora prolificans (Fig. 2). Identification was based on
classical morphological findings from colonies grown
on potato dextrose agar. The fungus had high mini-
mum inhibitory concentration (MIC) to amphotericin
(>32 mg/l) and itraconazole (>32 mg/L), and in-vitro
sensitivity to voriconazole (0.5 mg/L) using Etest
methodology (bioMerieux, USA).
The patient was commenced on therapy with vorico-
nazole (loading dose 600 mg IV 12 hourly). Unfortu-
nately, due to her underlying advanced malignancy,
disseminated fungal infection and poor clinical status,
she was considered unsuitable for surgical management.
She was managed with palliative intent and passed away
five days after the fungus was isolated on day 27 of her
admission.
Discussion
Endocarditis caused by Lomentospora prolificans is rare.
A Medline search was conducted using the terms Sce-
dosporium invasive infection, Scedosporium endocarditis,
Scedosporium prolificans endocarditis and disseminated
Scedosporium and Lomentospora endocarditis and infec-
tion. Eight cases were identified [5, 8–10]. Three patients
had underlying cardiac pathology: a prosthetic aortic
valve, an implanted permanent pacemaker or a history of
rheumatic disease. Four patients were immunosuppressed.
Fig. 2 Direct Gram stain from the aerobic blood culture bottle at 72 h
showing hyphae, conidiophores and conidia consistent with
Lomentospora prolificans (400 ×magnification)
Table 1 Cases of Lomentospora (Scedosporium) prolificans endocarditis 1990 – 2014
Case Year Age/Gender Predisposition Valve Complications Treatment/Surgery Outcome
1(5) 1990 30 male Intravenous drug user Mitral Septic arthritis AmBisome Survived
Flucytocine
2(5) 1997 67 female Prosthetic aortic valve Aortic Cerebral emboli AmBisome Died
Fluconazole
3(5) 2001 52 female Multiple myeloma Aortic Endophthalmitis, intracranial haemorrhage AmBisome Died
Itraconazole
AVR
4(5) 2006 75 male PPM PPM Pulmonary emboli Voriconazole Survived
PPM removal
5(9) 2010 50 male Rheumatic disease Mitral Septic shock AmBisome Died
MVR
6(5) 2010 29 female ALL Mitral Endophthalmitis, osteomyelitis & cerebral emboli AmBisome Died
Voriconazole
MVR
7(10) 2013 35 male Renal transplant Aortic Meningitis AmBisome Died
Voriconazole
8(8) 2014 66 female AML Mitral Sinusitis, pulmonary & splenic emboli Voriconazole Died
Terbinafine
Case 2014 75 female Ovarian cancer Aortic Cerebral emboli Voriconazole Died
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Of these, three had haematological malignancies and one
had previously received a renal transplant. One patient
was an injecting drug user. There were four men and four
women, with a mean age of 42 (range 29–75 years). The
majority of patients presented with fever, embolic
phenomenon and vegetations which were readily iden-
tified on echocardiography. Reported complications
included septic arthritis, endophthalmitis and menin-
gitis, along with cerebral, splenic and pulmonary
emboli. All except for two cases were treated with a
combination of liposomal amphotericin and either a
triazole or flucytosine. Two patients were treated with
voriconazole as the primary antifungal agent. Surgical
intervention was undertaken in half the cases. Of
those, only the patient whose infected pacemaker was
removed survived. Presentation is typically at an advanced
stage of dissemination and diagnostically challenging.
Mortality was high at 75 % (6/8) and immunocompetence
appeared to increase survival [5, 8–10]. The table below
includes our case (Table 1).
In this patient, the diagnosis of infective endocarditis
was based on the Duke clinical criteria, as no patho-
logical specimens were available. She fulfilled the criteria
as follows: 1 major, in the form of echocardiographic
findings on TOE, along with 3 minor; fever, embolic
phenomenon with cerebral lesions, and positive blood
cultures for Lomentospora prolificans. Despite advanced
malignancy, marantic (non-bacterial thrombotic endo-
carditis) was considered very unlikely due to the negative
FDG-PET imaging for active malignancy.
Matrix-assisted laser desorption ionisation-time of
flight mass spectromectry (MALDI-TOF) is being
increasingly utilised as an important and accurate
identification technique for Scedosporium species,
which may assist with optimising early empiric anti-
fungal treatment. In a recent study, MALDI-TOF
(using the Andromas system) was able to identify 64
Pseudallescheria and Scedosporium isolates with
100 % accuracy [11]. Polymerase chain reaction-based
restriction fragment methods have also proven useful
in accurately identifying L.prolificans, particularly
from small fungal concentrations [12].
There are no evidence based guidelines for treat-
ment. Surgical excision is paramount to patient sur-
vival. In the setting of endocarditis, cardiothoracic
intervention is required to excise the infected valve or
cardiac device. L.prolificans is resistant to many clas-
ses of antifungals. Of the triazole agents currently
available, including isavuconazole, voriconazole dem-
onstrates the most effect against L. prolificans in-
vitro, however the MIC90 remains >16 in most data
sets [13, 14]. Despite in-vitro susceptibility, clinical ef-
ficacy is often poor [4]. This is in contrast to S. aur-
antiacum which displays considerably lower MIC90
values to voriconazole [14]. Combination therapy has
been used with amphotericin and pentamidine, and
voriconazole combined with terbinafine. Optimal
length of treatment is unclear [1, 6, 13].
Conclusion
Endocarditis caused by Lomentospora prolificans is a
rare but emerging condition, with a high mortality and
limited treatment options. Survival is documented in
patients who have undergone aggressive surgical exci-
sion with valve replacement and anti-fungal therapy.
Awareness of the increasing incidence of invasive Lomen-
tospora prolificans infection, particularly in immunosup-
pressed patients, with a propensity to present late in
infection and potential for endocarditis may prompt earl-
ier echocardiography or FDG-PET imaging and guide
empiric antifungal therapy.
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